CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Masami KamedaMitsuo OtsukaHirofumi ChibaKoji KuronumaTakehiro HasegawaHiroki TakahashiHiroki TakahashiPublished in: PloS one (2020)
Serum CXCL9, CXCL10, and CXCL11 are potential biomarkers for autoimmune inflammation and predictors of the immunosuppressive therapy responses in ILD with background autoimmunity.